Seoulin BioscienceLtd Balance Sheet Health
Financial Health criteria checks 5/6
Seoulin BioscienceLtd has a total shareholder equity of ₩85.6B and total debt of ₩2.1B, which brings its debt-to-equity ratio to 2.4%. Its total assets and total liabilities are ₩102.8B and ₩17.2B respectively. Seoulin BioscienceLtd's EBIT is ₩1.4B making its interest coverage ratio 26.7. It has cash and short-term investments of ₩28.0B.
Key information
2.4%
Debt to equity ratio
₩2.08b
Debt
| Interest coverage ratio | 26.7x |
| Cash | ₩27.98b |
| Equity | ₩85.58b |
| Total liabilities | ₩17.20b |
| Total assets | ₩102.78b |
Recent financial health updates
No updates
Recent updates
Seoulin Bioscience Co.,Ltd. (KOSDAQ:038070) Is An Attractive Dividend Stock - Here's Why
May 03
Should Weakness in Seoulin Bioscience Co.,Ltd.'s (KOSDAQ:038070) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
Mar 13Introducing Seoulin BioscienceLtd (KOSDAQ:038070), A Stock That Climbed 54% In The Last Year
Feb 15Is Seoulin Bioscience Co.,Ltd. (KOSDAQ:038070) A Great Dividend Stock?
Jan 20
Three Days Left Until Seoulin Bioscience Co.,Ltd. (KOSDAQ:038070) Trades Ex-Dividend
Dec 25Is Seoulin Bioscience Co.,Ltd.'s (KOSDAQ:038070) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
Dec 06Financial Position Analysis
Short Term Liabilities: A038070's short term assets (₩62.5B) exceed its short term liabilities (₩15.9B).
Long Term Liabilities: A038070's short term assets (₩62.5B) exceed its long term liabilities (₩1.3B).
Debt to Equity History and Analysis
Debt Level: A038070 has more cash than its total debt.
Reducing Debt: A038070's debt to equity ratio has increased from 0.2% to 2.4% over the past 5 years.
Debt Coverage: A038070's debt is well covered by operating cash flow (225.6%).
Interest Coverage: A038070's interest payments on its debt are well covered by EBIT (26.7x coverage).